These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 25171251

  • 21. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.
    Trépo E, Pradat P, Potthoff A, Momozawa Y, Quertinmont E, Gustot T, Lemmers A, Berthillon P, Amininejad L, Chevallier M, Schlué J, Kreipe H, Devière J, Manns M, Trépo C, Sninsky J, Wedemeyer H, Franchimont D, Moreno C.
    Hepatology; 2011 Jul; 54(1):60-9. PubMed ID: 21488075
    [Abstract] [Full Text] [Related]

  • 22. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C.
    Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, Dongiovanni P, Maggioni M, Fracanzani AL, Rametta R, Colombo M, Fargion S.
    Hepatology; 2011 Mar; 53(3):791-9. PubMed ID: 21319195
    [Abstract] [Full Text] [Related]

  • 23. Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant.
    Palmer CN, Maglio C, Pirazzi C, Burza MA, Adiels M, Burch L, Donnelly LA, Colhoun H, Doney AS, Dillon JF, Pearson ER, McCarthy M, Hattersley AT, Frayling T, Morris AD, Peltonen M, Svensson PA, Jacobson P, Borén J, Sjöström L, Carlsson LM, Romeo S.
    PLoS One; 2012 Mar; 7(6):e39362. PubMed ID: 22724004
    [Abstract] [Full Text] [Related]

  • 24. The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
    Scheiner B, Mandorfer M, Schwabl P, Payer BA, Bucsics T, Bota S, Aichelburg MC, Grabmeier-Pfistershammer K, Stättermayer A, Ferenci P, Trauner M, Peck-Radosavljevic M, Reiberger T.
    PLoS One; 2015 Mar; 10(11):e0143429. PubMed ID: 26599080
    [Abstract] [Full Text] [Related]

  • 25. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.
    Romeo S, Sentinelli F, Cambuli VM, Incani M, Congiu T, Matta V, Pilia S, Huang-Doran I, Cossu E, Loche S, Baroni MG.
    J Hepatol; 2010 Aug; 53(2):335-8. PubMed ID: 20546964
    [Abstract] [Full Text] [Related]

  • 26. PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.
    Petta S, Vanni E, Bugianesi E, Rosso C, Cabibi D, Cammà C, Di Marco V, Eslam M, Grimaudo S, Macaluso FS, McLeod D, Pipitone RM, Abate ML, Smedile A, George J, Craxì A.
    Aliment Pharmacol Ther; 2015 May; 41(10):939-48. PubMed ID: 25801076
    [Abstract] [Full Text] [Related]

  • 27. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.
    Pirazzi C, Adiels M, Burza MA, Mancina RM, Levin M, Ståhlman M, Taskinen MR, Orho-Melander M, Perman J, Pujia A, Andersson L, Maglio C, Montalcini T, Wiklund O, Borén J, Romeo S.
    J Hepatol; 2012 Dec; 57(6):1276-82. PubMed ID: 22878467
    [Abstract] [Full Text] [Related]

  • 28. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
    Mandorfer M, Payer BA, Schwabl P, Steiner S, Ferlitsch A, Aichelburg MC, Stättermayer AF, Ferenci P, Obermayer-Pietsch B, Grabmeier-Pfistershammer K, Trauner M, Peck-Radosavljevic M, Reiberger T.
    Liver Int; 2015 Mar; 35(3):876-85. PubMed ID: 24905495
    [Abstract] [Full Text] [Related]

  • 29. The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP).
    Arslanow A, Stokes CS, Weber SN, Grünhage F, Lammert F, Krawczyk M.
    Liver Int; 2016 Mar; 36(3):418-26. PubMed ID: 26264356
    [Abstract] [Full Text] [Related]

  • 30. Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice.
    Lindén D, Ahnmark A, Pingitore P, Ciociola E, Ahlstedt I, Andréasson AC, Sasidharan K, Madeyski-Bengtson K, Zurek M, Mancina RM, Lindblom A, Bjursell M, Böttcher G, Ståhlman M, Bohlooly-Y M, Haynes WG, Carlsson B, Graham M, Lee R, Murray S, Valenti L, Bhanot S, Åkerblad P, Romeo S.
    Mol Metab; 2019 Apr; 22():49-61. PubMed ID: 30772256
    [Abstract] [Full Text] [Related]

  • 31. Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.
    Mandorfer M, Scheiner B, Stättermayer AF, Schwabl P, Paternostro R, Bauer D, Schaefer B, Zoller H, Peck-Radosavljevic M, Trauner M, Reiberger T, Ferenci P, Ferlitsch A.
    Aliment Pharmacol Ther; 2018 Aug; 48(4):451-459. PubMed ID: 29956823
    [Abstract] [Full Text] [Related]

  • 32. Long-term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals.
    Su H, Haque M, Becker S, Edlund K, Duda J, Wang Q, Reißing J, Marschall HU, Candels LS, Mohamed M, Sjöland W, Liao L, Drexler SA, Strowig T, Rahnenführer J, Hengstler JG, Hatting M, Trautwein C.
    Liver Int; 2023 Aug; 43(8):1699-1713. PubMed ID: 37073116
    [Abstract] [Full Text] [Related]

  • 33. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
    Donati B, Motta BM, Pingitore P, Meroni M, Pietrelli A, Alisi A, Petta S, Xing C, Dongiovanni P, del Menico B, Rametta R, Mancina RM, Badiali S, Fracanzani AL, Craxì A, Fargion S, Nobili V, Romeo S, Valenti L.
    Hepatology; 2016 Mar; 63(3):787-98. PubMed ID: 26605757
    [Abstract] [Full Text] [Related]

  • 34. Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response.
    Gavril OI, Arhire LI, Gavrilescu O, Dranga M, Barboi O, Gavril RS, Popescu R, Cijevschi Prelipcean C, Trifan AV, Mihai C.
    Medicina (Kaunas); 2021 Oct 24; 57(11):. PubMed ID: 34833371
    [Abstract] [Full Text] [Related]

  • 35. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.
    Rametta R, Ruscica M, Dongiovanni P, Macchi C, Fracanzani AL, Steffani L, Fargion S, Magni P, Valenti L.
    Eur J Clin Invest; 2014 Jul 24; 44(7):627-33. PubMed ID: 24828988
    [Abstract] [Full Text] [Related]

  • 36. A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection.
    Ali M, Yopp A, Gopal P, Beg MS, Zhu H, Lee W, Singal AG.
    Clin Gastroenterol Hepatol; 2016 Feb 24; 14(2):295-300. PubMed ID: 26305067
    [Abstract] [Full Text] [Related]

  • 37. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
    Krawczyk M, Rau M, Schattenberg JM, Bantel H, Pathil A, Demir M, Kluwe J, Boettler T, Lammert F, Geier A, NAFLD Clinical Study Group.
    J Lipid Res; 2017 Jan 24; 58(1):247-255. PubMed ID: 27836992
    [Abstract] [Full Text] [Related]

  • 38. PNPLA3 and TM6SF2 genetic variants and hepatic fibrosis and cirrhosis in Pakistani chronic hepatitis C patients: a genetic association study.
    Rauff B, Alzahrani B, Chudhary SA, Nasir B, Mahmood S, Bhinder MA, Faheem M, Amar A.
    BMC Gastroenterol; 2022 Aug 26; 22(1):401. PubMed ID: 36028802
    [Abstract] [Full Text] [Related]

  • 39. Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant.
    Mancina RM, Matikainen N, Maglio C, Söderlund S, Lundbom N, Hakkarainen A, Rametta R, Mozzi E, Fargion S, Valenti L, Romeo S, Taskinen MR, Borén J.
    J Clin Endocrinol Metab; 2015 May 26; 100(5):E821-5. PubMed ID: 25763607
    [Abstract] [Full Text] [Related]

  • 40. Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C.
    Valenti L, Colombo M, Fargion S.
    J Hepatol; 2011 Dec 26; 55(6):1470-1; author reply 1471-2. PubMed ID: 22100032
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.